VETERINARY ONCOLOGY MARKET ANALYSIS

Veterinary Oncology Market, By Animal Type (Companion Animal (Equine, Canine, and Feline) and Livestock Animal), By Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), By Mode of Administration (Oral and Intravenous), By Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Others), By Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : May 2024
Code : CMI2995
Pages :225
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Veterinary Oncology Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Awareness of Animal Health and Welfare

Increasing awareness of animal health and welfare and shifts in demographics and lifestyles leading to increased spending on pet healthcare are expected to drive the market growth over the forecast period. For instance, in May 2021, - Petco Health and Wellness Company, Inc., a complete partner in pet health and wellness, launched Together Strong, a pet cancer awareness campaign that brings two- and four-legged survivors together to highlight how routine preventative care is as vital for pets as it is for humans in the fight against cancer. Along with the campaign and in partnership with PetDx, a molecular diagnostics company aiming to revolutionize the detection, characterization and management of cancer in pets, Petco will begin offering OncoK9 a groundbreaking multi-cancer early detection test for dogs – at its full-service vet hospitals in select locations.

Key Players Insights